Harborside


Aleafia Health Inc.

TSE: AH


Canadian symbol: AH.TO
US symbol: ALEAF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 20.15M
Enterprise Value 59.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.37
Price/Book (mrq)1.04
Enterprise Value/Revenue 1.40
Enterprise Value/EBITDA -0.59

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3-83.33%
S&P500 52-Week Change 3-16.88%
52 Week High 30.3100
52 Week Low 30.0500
50-Day Moving Average 30.0661
200-Day Moving Average 30.0936

Share Statistics

Avg Vol (3 month) 3286.15k
Avg Vol (10 day) 3330.77k
Shares Outstanding 5403.01M
Implied Shares Outstanding 6N/A
Float 8396.73M
% Held by Insiders 11.51%
% Held by Institutions 10.02%
Shares Short (Sept 14, 2022) 4116.28k
Short Ratio (Sept 14, 2022) 40.38
Short % of Float (Sept 14, 2022) 4N/A
Short % of Shares Outstanding (Sept 14, 2022) 40.03%
Shares Short (prior month Aug 14, 2022) 4300.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 08, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-121.11%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)35.85M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)12.70%
Gross Profit (ttm)-9.56M
EBITDA -34.44M
Net Income Avi to Common (ttm)-145.59M
Diluted EPS (ttm)-0.5080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.46M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)44.93M
Total Debt/Equity (mrq)231.65
Current Ratio (mrq)1.20
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-19.74M
Levered Free Cash Flow (ttm)N/A

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
1 month ago
AH.TO
Aleafia Health
2 months ago
AH.TO
Aleafia Health
2 months ago
AH.TO
Aleafia Health
2 months ago
AH.TO
Aleafia Health
2 months ago
AH.TO
Aleafia Health
4 months ago
AH.TO
Aleafia Health
5 months ago
AH.TO
Aleafia Health
5 months ago
AH.TO
Aleafia Health
5 months ago
AH.TO
Aleafia Health
7 months ago
AH.TO
Aleafia Health
7 months ago
AH.TO
Aleafia Health
7 months ago
AH.TO
Aleafia Health
7 months ago
AH.TO
Aleafia Health
9 months ago
AH.TO
Aleafia Health
9 months ago
AH.TO
Aleafia Health
10 months ago
AH.TO
Aleafia Health
10 months ago
AH.TO
Aleafia Health
11 months ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
1 year ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
2 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago
AH.TO
Aleafia Health
3 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2023)Next Year (2024)
No. of Analysts1111
Avg. Estimate-0.01-0.01-0.05-0.03
Low Estimate-0.01-0.01-0.05-0.03
High Estimate-0.01-0.01-0.05-0.03
Year Ago EPS0-0.25N/A-0.05
Revenue EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2023)Next Year (2024)
No. of Analysts1221
Avg. Estimate12.03M11.45M48.95M74.2M
Low Estimate8.8M10M43M74.2M
High Estimate8.8M12.9M54.9M74.2M
Year Ago SalesN/AN/AN/A48.95M
Sales Growth (year/est)N/AN/AN/A51.60%
Earnings History2021-06-292021-09-292021-12-302022-03-30
EPS Est.-0.01-0.02-0.01-0.02
EPS Actual0-0.25-0.13-0.01
Difference0.01-0.23-0.120.01
Surprise %100.00%-1,150.00%-1,200.00%50.00%
EPS TrendCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2023)Next Year (2024)
Current Estimate-0.01-0.01-0.05-0.03
7 Days Ago-0.01-0.01-0.04-0.02
30 Days Ago-0.01-0.01-0.04-0.02
60 Days Ago-0.01-0.01-0.04-0.2
90 Days Ago-0.02-0.0100
EPS RevisionsCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/A111
Up Last 30 DaysN/A111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAH.TOIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.96.00%N/AN/AN/A
Current YearN/AN/AN/AN/A
Next Year40.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
1.51%% of Shares Held by All Insider
0.02%% of Shares Held by Institutions
0.02%% of Float Held by Institutions
2Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Captrust Financial Advisors3,427Jun 29, 20220.00%171

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF124,904May 30, 20220.03%6,245
Amplify Seymour Cannabis ETF77,872Apr 29, 20220.02%3,893
DFA Investment Dimensions-DFA Va International Small9,500Jan 30, 20220.00%475
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Aleafia Health Inc.


Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

TORONTO, Sept. 16, 2022 -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted. Fo... Read More...
Aleafia Health Announces $12.0 Million Total Net Revenue in First Quarter, Representing a 13% Increase Over the Prior Year

Aleafia Health Announces $12.0 Million Total Net Revenue in First Quarter, Representing a 13% Increase Over the Prior Year

31% increase in branded cannabis net revenue1 to $10.0 million from $7.6 million in the prior year#12 ranking for market share in core markets2 for Q1 FY2023In the Ontario value category, Divvy has attained #5 market share in pre-roll and #7 in flower Secured new international partnership representing approximately $4.6 million sales comm... Read More...
Aleafia Health to Announce Fiscal Year 2023 First Quarter Results

Aleafia Health to Announce Fiscal Year 2023 First Quarter Results

TORONTO, Aug. 04, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on August 11 prior to market open its fiscal year 2023 first quarter results for the period ending June 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be ho... Read More...
Aleafia Health Announces Closing of Debenture Amendment Transaction

Aleafia Health Announces Closing of Debenture Amendment Transaction

TORONTO, June 28, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced amendment of its unsecured convertible debentures (the “Debenture Amendments”). “We are delighted we have now completed this transaction,” said Tricia Symmes Aleafia H... Read More...
Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5

Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5

151% increase in branded cannabis net revenue1 to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million in the prior 12-month year$8 million in branded cannabis net revenue for Q5, a growth of 55% calendar year over calendar year 3rd highest increase in overall market share rankings over ... Read More...
Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

TORONTO, June 24, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 28, 2022, prior to market open, its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will... Read More...
Aleafia Health Inc. Announces Closing of $5.6M Private Placement

Aleafia Health Inc. Announces Closing of $5.6M Private Placement

TORONTO, June 24, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) representing aggregate gross proceeds of approximately $5.6 million. Pursuant to the Private Placement, an aggregate of 68,... Read More...
Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

TORONTO, June 15, 2022 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 23 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be host... Read More...
Aleafia Health Announces Update Regarding Agreement to Amend Convertible Debentures and Equity Financing

Aleafia Health Announces Update Regarding Agreement to Amend Convertible Debentures and Equity Financing

Debentureholders representing approximately 61.4% of the Convertible Debentures outstanding have entered into Support Agreements1, including each member of the Steering Committee nominated by DebentureholdersCompany more than 90% towards achieving a minimum of 66 2/3% required to pass the Debenture AmendmentsDebentureholders of record as ... Read More...
Aleafia Health Implementing $6.7 Million in Annualized Cost Savings in 2022 and Reaffirms Guidance

Aleafia Health Implementing $6.7 Million in Annualized Cost Savings in 2022 and Reaffirms Guidance

$4.4 million annualized cost reductions being implemented in addition to $2.3 million announced in February 2022Grimsby, Ontario cultivation organization realigned to support anticipated growth in product throughputOrganizational realignment in the medical business to fully integrate the sales channelsCore corporate shared services consol... Read More...
Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth

Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth

Reached new record market share overall adult use market share of 2.06% in February 2022, advancing 33% from 1.54% in November 2021(1)Continued ascent in overall market share rankings, up two more notches to 13th in February 2022 from 15th in November 2021On the pathway towards a top 10 market share position by the end of 2022 Received fi... Read More...
Aleafia Health Reports Q4 2021 Financial Results with $11.5 Million Branded Cannabis Gross Revenue, representing a 103% Increase from 2020

Aleafia Health Reports Q4 2021 Financial Results with $11.5 Million Branded Cannabis Gross Revenue, representing a 103% Increase from 2020

Transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 202096% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in 202060% in... Read More...
Aleafia Health Appoints Tricia Symmes as CEO to Replace Geoffrey Benic

Aleafia Health Appoints Tricia Symmes as CEO to Replace Geoffrey Benic

TORONTO, Feb. 07, 2022 -- The Board of Directors of Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) today announced that CEO Geoffrey Benic will leave the Company, effective February 7, 2022. To succeed Benic, the Board named Tricia Symmes, previously the Company’s Chief Commercial Officer (CCO), as the Com... Read More...
Aleafia Health Provides Update on the Negotiation of its Convertible Debt

Aleafia Health Provides Update on the Negotiation of its Convertible Debt

TORONTO, Jan. 04, 2022 -- Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”). The Company has initiated negotiati... Read More...
Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

Credit Facility provides the Company with liquidity to fund operations and organic growth initiativesTwo-year term provides additional financial flexibility TORONTO, Dec. 29, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million ... Read More...
Aleafia Health to Announce 2021 Third Quarter Results

Aleafia Health to Announce 2021 Third Quarter Results

TORONTO, Nov. 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 third quarter results on November 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt S... Read More...
Aleafia Health Announces Appointment of David Pasieka to Board of Directors

Aleafia Health Announces Appointment of David Pasieka to Board of Directors

TORONTO, Sept. 01, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the appointment of David Pasieka to its board of directors. Mr. Pasieka is a seasoned public company executive and director with extensive board level experience in finance & audit, risk management, and ESG... Read More...
Aleafia Health Reports Strong 2021 Second Quarter Financial Results with 53% Sequential Increase in Cannabis Net Revenue

Aleafia Health Reports Strong 2021 Second Quarter Financial Results with 53% Sequential Increase in Cannabis Net Revenue

Adult-use cannabis net revenue increased 87% compared to the prior quarterMedical cannabis net revenue increased 23% compared to the prior quarter13 additional product SKUs released across multiple product formatsFor the first time, medical cannabis product was made available for sale in GermanyCommenced onboarding of medical cannabis pat... Read More...
Aleafia Health to Announce 2021 Second Quarter Results

Aleafia Health to Announce 2021 Second Quarter Results

TORONTO, Aug. 04, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 second quarter results on August 12, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sa... Read More...
Aleafia Health Announces the Appointment of Mark J. Sandler as Board Chair

Aleafia Health Announces the Appointment of Mark J. Sandler as Board Chair

TORONTO, July 29, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) a global leader in cannabis wellness products and services, is pleased to announce the appointment of Mark J. Sandler as Chairman of its Board of Directors (the “Board”). He is the longest serving member of the Company’s board, which ... Read More...
Aleafia Health Expands Bogart's Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

TORONTO, June 24, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced the expansion of its cannabis edibles portfolio with the first of its kind of Salted Caramel Pretzel Bites. The new format is now available and sold under th... Read More...
Aleafia Health Appoints Finance Executive Matt Sale as Chief Financial Officer

Aleafia Health Appoints Finance Executive Matt Sale as Chief Financial Officer

TORONTO, June 21, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce the appointment of Matt Sale to its executive leadership team as chief financial officer, effective today. Mr. Sale is a proven finance professional w... Read More...
Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET

Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET

TORONTO, June 15, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced that CEO Geoffrey Benic will participate in the Cantor Fitzgerald Canadian LPs Cannabis Forum on June 16. Wednesday, June 1610:00 a.m. ETRegistration Link For Investor & Media Relations Nicholas Bergamini, VP Inve... Read More...
Aleafia Health's Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

Aleafia Health’s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

TORONTO, June 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced the continued expansion of its dried flower portfolio with the launch of four new large format offerings under its everyday cannabis brand Divvy. The new products strengthen the existing Divvy portfolio following a su... Read More...
Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany

Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany

TORONTO, June 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that dried flower grown at its Niagara greenhouse facility has been successfully exported to Germany. Gaining access to Europe’s most mature legal can... Read More...
Aleafia Health to Present at Canaccord Genuity's Global Cannabis Conference on May 11, 2021

Aleafia Health to Present at Canaccord Genuity’s Global Cannabis Conference on May 11, 2021

TORONTO, May 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that CEO Geoffrey Benic will present at Canaccord Genuity’s Global Cannabis Conference on Tuesday, May 11, 2021 at 11:00 a.m. EDT. Participants can acc... Read More...
Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.

Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.

TORONTO, May 10, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its wholly-owned subsidiaries, Canabo Medical Corporation (“Canabo”) and GrowWise Health Limited (“GrowWise”), (together the “Vendors”) have closed a transaction (the “Transaction”) with Myconic Capital Corp... Read More...
Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

TORONTO, May 03, 2021 -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human senso... Read More...
Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels

Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels

TORONTO, April 13, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath bombs, both o... Read More...
Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue

Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue

233% increase in Q/Q cannabis net revenue$4.3 million positive adjusted EBITDA in Q4 202042% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectivelySignificant product portfolio expansion with 31 new SKUs launched since October TORONTO, March 25, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health”... Read More...
Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

TORONTO, March 16, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its products are now available to consumers in Saskatchewan. The initial provincial launch includes a broad array of Aleafia Health’s cannabis product portfolio, including sublingual strips, cannabis oils, d... Read More...
Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, March 09, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced bought deal offering (the “Offering”) for a total issuance of 27,390,00... Read More...
Aleafia Health to Announce 2020 Fourth Quarter and Year End Results

Aleafia Health to Announce 2020 Fourth Quarter and Year End Results

TORONTO, Feb. 25, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2020 fourth quarter and fiscal year results on March 25, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Geoffrey Benic a... Read More...
Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million

Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million

TORONTO, Feb. 17, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has agreed to increase the size of its previously announced “bought deal” offering of units led by Cantor Fitzgerald Canada Corporation as lead underwriter and sole bookrunner, on behalf of a syndicate of ... Read More...
Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

TORONTO, Feb. 16, 2021 -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced its wholly owned subsidiary Emblem Cannabis Corporation has received a Health Canada Processing Licence (the “Licence”) for its new Distribution Centre (the “DC”). Located minutes from Toronto Pearson International Airpo... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,692.200.03%Negative
Euro STOXX 503,360.880.37%Positive
FTSE 1006,988.520.43%Negative
Nikkei 22526,431.552.66%Negative

Delayed data (1h)
IndexLast% Change
S&P 5003,692.200.03%Negative
Euro STOXX 503,360.880.37%Positive
FTSE 1006,988.520.43%Negative
Nikkei 22526,431.552.66%Negative


Share this page